Brazil Minimally Invasive Surgery Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Brazil represents the single largest medical device market in Latin America, and MIS devices form one of its fastest-growing sub-segments. The country benefits from a large patient pool, a well-developed private hospital sector, and a regulatory environment overseen by ANVISA that has become progressively more transparent for device approvals. PublicSistema Único de Saúde (SUS) procurement and private hospital modernization programs are jointly expanding the installed base of advanced surgical equipment.

• •Market size estimated at USD 1.24 billion in 2025 with a projected CAGR of approximately 7.98%
• •Brazil accounts for the largest share of MIS device demand within Latin America
• •ANVISA regulates device approvals, with private hospitals driving premium-technology adoption

The principal growth drivers are demographic and epidemiological: Brazil's aging population and rising incidence of cardiovascular disease, cancer, obesity, and orthopedic conditions are increasing the volume of surgical procedures that can be performed minimally invasively. At the same time, hospitals are under pressure to reduce inpatient length of stay and post-operative complications, both of which favor MIS approaches over open surgery. Wider surgeon training programs and greater reimbursement coverage for laparoscopic procedures are also accelerating adoption.

• •Rising chronic disease burden, particularly cancer, cardiovascular, and obesity-related conditions
• •Demand for shorter hospital stays and reduced post-operative complications
• •Expanding surgeon training in laparoscopy and robotic-assisted techniques

By product, the market is typically segmented into surgical instruments, endoscopy/laparoscopy devices, monitoring and visualization systems, and robotic-assisted surgical systems, with conventional laparoscopy instruments currently representing the largest share. By application, general surgery, gynecology, urology, orthopedics, and cardiothoracic surgery are the leading categories, while by end user private hospitals account for the majority of high-value equipment purchases. Geographically, demand is concentrated in the Southeast, especially São Paulo and Rio de Janeiro, followed by the South and Northeast regions as private hospital chains expand.

• •Laparoscopy and endoscopy devices represent the dominant product segment
• •Private hospitals are the leading end-user segment, with public SUS hospitals a growing secondary channel
• •Southeast Brazil (São Paulo, Rio de Janeiro) accounts for the largest regional share of demand

What are the recent trends and outlook?

The most significant trends shaping the market through 2030 include the gradual adoption of robotic-assisted surgical platforms, growing use of single-incision and natural orifice transluminal endoscopic surgery (NOTES) techniques, and integration of AI-enabled imaging and visualization tools. Manufacturers are also localizing assembly and packaging operations in Brazil to navigate import duties under ANVISA and to meet public procurement preferences. With strong demographic tailwinds and ongoing hospital modernization, the market is expected to maintain growth of roughly 7-8% annually through the end of the decade.

• •Robotic-assisted and single-incision laparoscopy are the fastest-growing technology segments
• •AI-driven imaging, 3D visualization, and energy-based devices are increasingly integrated into MIS platforms
• •Local manufacturing and assembly partnerships are expanding to reduce import dependency